Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial
Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial
description
article
@en
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Safety and tolerability of a s ...... s aureus: first-in-human trial
@en
Safety and tolerability of a s ...... s aureus: first-in-human trial
@nl
type
label
Safety and tolerability of a s ...... s aureus: first-in-human trial
@en
Safety and tolerability of a s ...... s aureus: first-in-human trial
@nl
prefLabel
Safety and tolerability of a s ...... s aureus: first-in-human trial
@en
Safety and tolerability of a s ...... s aureus: first-in-human trial
@nl
P2093
P1476
Safety and tolerability of a s ...... s aureus: first-in-human trial
@en
P2093
Arnaud Desachy
Céline Gonzalez
Emmanuelle Mercier
Ferhat Meziani
Gaëtan Plantefève
Karim Asehnoune
MASTER 1 study group
Maud Fiancette
Paul-André de Lame
Pierre-François Laterre
P304
P356
10.1007/S00134-018-5229-2
P407
P577
2018-10-21T00:00:00Z